{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:40:52Z","timestamp":1792478452569,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","revespcardiol.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.rec.2024.02.014","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T08:07:51Z","timestamp":1710230871000},"page":"843-850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A systematic review and meta-analysis of mortality in chronic Chagas cardiomyopathy versus other cardiomyopathies: higher risk or fiction?"],"prefix":"10.1016","volume":"77","author":[{"given":"Sergio A.","family":"G\u00f3mez-Ochoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie Yarlady","family":"Serrano-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Hurtado-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Aceros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyda Z.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Echeverr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2024.02.014_bib0285","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5334\/gh.1150","article-title":"Global, Regional, and National Trends of Chagas Disease from 1990 to 2019: Comprehensive Analysis of the Global Burden of Disease Study","volume":"17","author":"G\u00f3mez-Ochoa","year":"2022","journal-title":"Glob Heart."},{"key":"10.1016\/j.rec.2024.02.014_bib0290","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.idc.2018.10.015","article-title":"American Trypanosomiasis (Chagas Disease)","volume":"33","author":"Echeverria","year":"2019","journal-title":"Infect Dis Clin North Am."},{"key":"10.1016\/j.rec.2024.02.014_bib0295","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCHEARTFAILURE.109.882035","article-title":"Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial","volume":"3","author":"Issa","year":"2010","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.rec.2024.02.014_bib0300","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13071-016-1315-x","article-title":"Increased mortality attributed to Chagas disease: a systematic review and meta-analysis","volume":"9","author":"Cucunub\u00e1","year":"2016","journal-title":"Parasit Vectors."},{"key":"10.1016\/j.rec.2024.02.014_bib0305","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/ije\/dys125","article-title":"Risk of cardiovascular events associated with positive serology for Chagas: a systematic review","volume":"41","author":"Linetzky","year":"2012","journal-title":"Int J Epidemiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0310","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan. A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Systematic Reviews."},{"key":"10.1016\/j.rec.2024.02.014_bib0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol."},{"key":"10.1016\/j.rec.2024.02.014_bib0320","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1590\/S0066-782X2007000600007","article-title":"Evaluation of heart failure prognostic factors in patients referred for heart transplantation","volume":"88","author":"Areosa","year":"2007","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0325","doi-asserted-by":"crossref","first-page":"e2176","DOI":"10.1371\/journal.pntd.0002176","article-title":"Mode of death on Chagas heart disease: comparison with other etiologies. a subanalysis of the REMADHE prospective trial","volume":"7","author":"Ayub-Ferreira","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.rec.2024.02.014_bib0330","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1590\/S0066-782X2011005000112","article-title":"Comparison of outcome between Chagas cardiomyopathy and idiopathic dilated cardiomyopathy","volume":"97","author":"Barbosa","year":"2011","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0335","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/europace\/eut011","article-title":"Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease","volume":"15","author":"Barbosa","year":"2013","journal-title":"Europace."},{"key":"10.1016\/j.rec.2024.02.014_bib0340","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.healun.2009.10.014","article-title":"Prognostic impact of Chagas\u2019 disease in patients awaiting heart transplantation","volume":"29","author":"Bertolino","year":"2010","journal-title":"J Heart Lung Transplant."},{"key":"10.1016\/j.rec.2024.02.014_bib0345","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0167-5273(97)00083-1","article-title":"Clinical course of Chagas\u2019 heart disease: a comparison with dilated cardiomyopathy","volume":"60","author":"Bestetti","year":"1997","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0350","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.ijcard.2013.04.015","article-title":"Prognosis of patients with chronic systolic heart failure: Chagas disease versus systemic arterial hypertension","volume":"168","author":"Bestetti","year":"2013","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0355","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0972-6292(16)30773-2","article-title":"Repolarization parameters are associated with mortality in chagas disease patients in the United States","volume":"14","author":"Bradfield","year":"2014","journal-title":"Indian Pacing Electrophysiol J."},{"key":"10.1016\/j.rec.2024.02.014_bib0360","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijcard.2007.01.097","article-title":"Is Chagas cardiomyopathy an independent risk factor for patients with heart failure?","volume":"126","author":"Braga","year":"2008","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0365","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1590\/S0066-782X2010005000112","article-title":"[Chagas cardiomyopathy: prognosis in clinical and hemodynamic profile C]","volume":"95","author":"Cardoso","year":"2010","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0370","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/17474930211006284","article-title":"Chagas disease is an independent predictor of stroke and death in a cohort of heart failure patients","volume":"17","author":"Cerqueira-Silva","year":"2022","journal-title":"Int J Stroke."},{"key":"10.1016\/j.rec.2024.02.014_bib0375","article-title":"In-Hospital Management and Long-term Clinical Outcomes and Adherence in Patients With Acute Decompensated Heart Failure: Primary Results of the First Brazilian Registry of Heart Failure (BREATHE)","author":"de Albuquerque","year":"2023","journal-title":"J Card Fail."},{"key":"10.1016\/j.rec.2024.02.014_bib0380","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2005.11.009","article-title":"Socioeconomic factors in the prognosis of heart failure in a Brazilian cohort","volume":"113","author":"de Campos Lopes","year":"2006","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0385","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/jce.14164","article-title":"Chagas disease is associated with a worse prognosis at 1-year follow-up after implantable cardioverter-defibrillator for secondary prevention in heart failure patients","volume":"30","author":"Vieira de Melo","year":"2019","journal-title":"J Cardiovasc Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0390","first-page":"161","article-title":"Major clinical characteristics of patients surviving 24 months or more after hospitalization due to decompensated heart failure","volume":"84","author":"Oliveira","year":"2005","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0395","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1542-474X.2005.00060.x","article-title":"A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study","volume":"10","author":"Dubner","year":"2005","journal-title":"Ann Noninvasive Electrocardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0400","doi-asserted-by":"crossref","first-page":"101964","DOI":"10.1016\/j.cpcardiol.2023.101964","article-title":"Characterization of Patients With Heart Failure of Chagas Etiology in Colombia: An Analysis Based on the Colombian Registry of Heart Failure (RECOLFACA)","volume":"48","author":"Echeverr\u00eda","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.rec.2024.02.014_bib0405","first-page":"662","article-title":"ICD implant without defibrillation threshold testing: patients with Chagas disease versus patients with ischemic cardiomyopathy","volume":"3","author":"Femen\u00eda","year":"2012","journal-title":"J Innov Card Rhythm Manag."},{"key":"10.1016\/j.rec.2024.02.014_bib0410","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2004.05.025","article-title":"Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas\u2019 heart disease","volume":"102","author":"Freitas","year":"2005","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0415","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1590\/S0100-879X2009000500004","article-title":"Association of HDL cholesterol and triglycerides with mortality in patients with heart failure","volume":"42","author":"Freitas","year":"2009","journal-title":"Braz J Med Biol Res."},{"key":"10.1016\/j.rec.2024.02.014_bib0420","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.fjc.0000249892.22635.46","article-title":"Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?","volume":"48","author":"Heringer-Walther","year":"2006","journal-title":"J Cardiovasc Pharmacol."},{"key":"10.1016\/j.rec.2024.02.014_bib0425","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/europace\/eux375","article-title":"A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy","volume":"20","author":"Martinelli Filho","year":"2018","journal-title":"Europace."},{"key":"10.1016\/j.rec.2024.02.014_bib0430","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/heartjnl-2017-312869","article-title":"Temporal trends in the contribution of Chagas cardiomyopathy to mortality among patients with heart failure","volume":"104","author":"Nadruz","year":"2018","journal-title":"Heart."},{"key":"10.1016\/j.rec.2024.02.014_bib0435","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/ehf2.12770","article-title":"The use of the CALL Risk Score for predicting mortality in Brazilian heart failure patients","volume":"7","author":"Nakazone","year":"2020","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.rec.2024.02.014_bib0440","first-page":"788","article-title":"Predictors of mortality in patients with dilated cardiomyopathy: relevance of chagas disease as an etiological factor","volume":"63","author":"Pereira Nunes","year":"2010","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0445","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1590\/S0066-782X2006001900012","article-title":"The role of storage of interstitial myocardial collagen on the overlife rate of patients with idiopathic and Chagasic dilated cardiomyopathy","volume":"87","author":"Nunes","year":"2006","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0450","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S1807-59322011000200010","article-title":"Predictors of low cardiac output in decompensated severe heart failure","volume":"66","author":"Ochiai","year":"2011","journal-title":"Clinics (Sao Paulo)."},{"key":"10.1016\/j.rec.2024.02.014_bib0455","article-title":"Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts","volume":"9","author":"Olivera","year":"2022","journal-title":"Ther Adv Infect Dis."},{"key":"10.1016\/j.rec.2024.02.014_bib0460","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1590\/1806-9282.65.11.1391","article-title":"Chagas disease is associated with a poor outcome at 1-year follow-up after cardiac resynchronization therapy","volume":"65","author":"Passos","year":"2019","journal-title":"Rev Assoc Med Bras (1992)."},{"key":"10.1016\/j.rec.2024.02.014_bib0465","first-page":"99","article-title":"Clinical Course After Cardioverter-Defibrillator Implantation: Chagasic Versus Ischemic Patients","volume":"107","author":"Pereira","year":"2016","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0470","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1590\/S0066-782X2005000400007","article-title":"Survival and prognostic factors in systolic heart failure with recent symptom onset","volume":"84","author":"Rassi","year":"2005","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0475","doi-asserted-by":"crossref","first-page":"e004361","DOI":"10.1161\/CIRCHEARTFAILURE.117.004361","article-title":"Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy","volume":"10","author":"Shen","year":"2017","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.rec.2024.02.014_bib0480","first-page":"358","article-title":"Why do patients with chagasic cardiomyopathy have worse outcomes than those with non-chagasic cardiomyopathy?","volume":"91","author":"Silva","year":"2008","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0485","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/CIRCHEARTFAILURE.115.002229","article-title":"Prevalence and Impact of Chagas Disease Among Latin American Immigrants With Nonischemic Cardiomyopathy in Los Angeles, California","volume":"8","author":"Traina","year":"2015","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.rec.2024.02.014_bib0490","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijcard.2012.01.033","article-title":"Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy","volume":"167","author":"Vilas Boas","year":"2013","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0495","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2008.11.089","article-title":"Anemia and renal failure as predictors of risk in a mainly non-ischemic heart failure population","volume":"141","author":"Ferreira","year":"2010","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.02.014_bib0500","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4269\/ajtmh.22-0630","article-title":"Risk Factors for Progression to Chronic Chagas Cardiomyopathy: A Systematic Review and Meta-Analysis","volume":"108","author":"Cutshaw","year":"2023","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.rec.2024.02.014_bib0505","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9343(99)00126-6","article-title":"Risk factors for heart failure in the elderly: a prospective community-based study","volume":"106","author":"Chen","year":"1999","journal-title":"Am J Med."},{"key":"10.1016\/j.rec.2024.02.014_bib0510","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jchf.2021.05.005","article-title":"Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS","volume":"9","author":"Caponetti","year":"2021","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.rec.2024.02.014_bib0515","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3390\/jcm10112289","article-title":"Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy","volume":"10","author":"Jain","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.rec.2024.02.014_bib0520","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ejhf.2495","article-title":"Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank","volume":"24","author":"Rastogi","year":"2022","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2024.02.014_bib0525","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1161\/CIR.0000000000000599","article-title":"Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association","volume":"138","author":"Nunes","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2024.02.014_bib0530","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s10554-020-01925-2","article-title":"Cardiac magnetic resonance imaging in Chagas\u2019 disease: a parallel with electrophysiologic studies","volume":"36","author":"Duran-Crane","year":"2020","journal-title":"Int J Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2024.02.014_bib0535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.thromres.2021.02.025","article-title":"Coagulation disorders in Chagas disease: A pathophysiological systematic review and meta-analysis","volume":"201","author":"Echeverr\u00eda","year":"2021","journal-title":"Thromb Res."},{"key":"10.1016\/j.rec.2024.02.014_bib0540","doi-asserted-by":"crossref","first-page":"165642","DOI":"10.1016\/j.bbadis.2019.165642","article-title":"Immune-neuroendocrine and metabolic disorders in human and experimental T. cruzi infection: New clues for understanding Chagas disease pathology","volume":"1866","author":"Gonz\u00e1lez","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"10.1016\/j.rec.2024.02.014_bib0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0046-8177(00)80191-4","article-title":"Cardiac autonomic denervation in congestive heart failure: comparison of Chagas\u2019 heart disease with other dilated cardiomyopathy","volume":"31","author":"Machado","year":"2000","journal-title":"Hum Pathol."},{"key":"10.1016\/j.rec.2024.02.014_bib0550","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ehf2.12240","article-title":"Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial","volume":"5","author":"Bocchi","year":"2018","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.rec.2024.02.014_bib0555","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/ehf2.12355","volume":"5","author":"Ramires","year":"2018","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.rec.2024.02.014_bib0560","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0140-6736(20)30171-9","article-title":"Chagas disease: still a neglected emergency?","volume":"395","author":"Lopes","year":"2020","journal-title":"Lancet."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S188558572400094X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S188558572400094X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T11:53:31Z","timestamp":1727351611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S188558572400094X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S188558572400094X"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2024.02.014","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of mortality in chronic Chagas cardiomyopathy versus other cardiomyopathies: higher risk or fiction?","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2024.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2024.02.022","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}